解码雄激素受体信号:在前列腺癌中基因组与非基因组的作用
1Androgen Signalling Laboratory, Faculty of Health & Medical Sciences, University of Surrey, Guildford, United Kingdom.
概括
较低的雄激素水平通过非基因组雄激素受体 (AR) 单体作用促进前列腺癌的扩散. 高水平通过基因组AR二次体活性抑制生长,表明新的治疗点.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 雄激素受体 (AR) 调解男性性激素的作用,表现出不同的生理和病理效应.
- 非基因组AR作用迅速激活促增殖途径,与传统的转录因子模型有所不同.
- 了解不同的雄激素反应对于前列腺癌等疾病至关重要.
研究的目的:
- 为了研究不同水平的雄激素受体 (AR) 在前列腺癌中作用的独特机制.
- 阐明AR单体和双体在癌症扩散和抑制中的作用.
- 确定针对特定AR形式的新型治疗策略.
主要方法:
- 萨菲等人的分析. 的研究是关于前列腺癌中的雄激素受体 (AR) 功能.
- 检查涉及AR单体的非基因组信号通路.
- 通过AR二元介导的基因组信号通路的研究.
主要成果:
- 较低的雄激素水平通过非基因组AR单体活性刺激前列腺癌细胞的增殖.
- 高的雄激素水平通过基因组AR二元介导的作用抑制癌症生长.
- AR单体在癌症进展和治疗耐药性方面发挥着重要作用.
结论:
- 雄激素受体 (AR) 在前列腺癌中发挥双重作用,这取决于激素水平和AR构成 (单体与二元).
- 这些发现挑战了癌症中AR功能的现有范式.
- 针对AR单体和二元形式的向为新型前列腺癌疗法提供了潜力,特别是解决耐药性.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Signal Transduction: Overview
8.2K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
8.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


